Literature DB >> 1082188

Multiple target cell killing by the cytolytic T lymphocyte and the mechanism of cytotoxicity.

E Martz.   

Abstract

Previous reports have shown that one cytolytic T lymphocyte (CTL) can kill more than one allogeneic target cell, but have not established whether after its action on one or more target cells, each CTL can attack a second set of target cells at a later time. The experiments described here show that one CTL can kill more than six target cells, and they suggest that CTL can do this sequentially in time. Hence, the small number of specifically sensitized lymphocytes found in rejecting grafts could play an important role. Moreover, sequential killing would imply that CTL are not harmed during their interaction with specific target cells. If killing were effected by secretion of a nonspecific toxin, the killer cell would then have evolved some device for resisting its own toxin in order to survive. Whether or not this is the case has not yet been fully resolved.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082188     DOI: 10.1097/00007890-197601000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  The partial isolation of subcellular MHC products which are recognized by alloimmune T lymphocytes.

Authors:  J C Roder; K Karre
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

Review 2.  Mechanisms and functions for the duration of intercellular contacts made by lymphocytes.

Authors:  Daniel M Davis
Journal:  Nat Rev Immunol       Date:  2009-07-17       Impact factor: 53.106

Review 3.  Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.

Authors:  Prasad V Phatarpekar; Daniel D Billadeau
Journal:  J Cell Sci       Date:  2020-02-21       Impact factor: 5.285

4.  Cytotoxicity of lymphocytes in the newborn.

Authors:  M Xanthou; H Mandyla-Sfagou; C Economou-Mavrou; N Matsaniotis
Journal:  Arch Dis Child       Date:  1981-05       Impact factor: 3.791

Review 5.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Authors:  William R Strohl; Michael Naso
Journal:  Antibodies (Basel)       Date:  2019-07-03

6.  Immune T lymphocyte to tumor cell adhesion. Magnesium sufficient, calcium insufficient.

Authors:  E Martz
Journal:  J Cell Biol       Date:  1980-03       Impact factor: 10.539

7.  Inflammatory bowel disease: study of cell mediated cytotoxicity for isolated human colonic epithelial cells.

Authors:  B J Kemler; E Alpert
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

8.  Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies.

Authors:  Rauf Bhat; Carsten Watzl
Journal:  PLoS One       Date:  2007-03-28       Impact factor: 3.240

Review 9.  The Application of Nanobody in CAR-T Therapy.

Authors:  Chaolemeng Bao; Quanli Gao; Lin-Lin Li; Lu Han; Bingxiang Zhang; Yijin Ding; Zongpei Song; Ruining Zhang; Jishuai Zhang; Xian-Hui Wu
Journal:  Biomolecules       Date:  2021-02-08

10.  Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells.

Authors:  Katja Srpan; Ashley Ambrose; Alexandros Karampatzakis; Mezida Saeed; Adam N R Cartwright; Karolin Guldevall; Gabriela Dos Santos Cruz De Matos; Björn Önfelt; Daniel M Davis
Journal:  J Cell Biol       Date:  2018-07-02       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.